PMID- 34934625 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231108 IS - 2214-031X (Print) IS - 2214-0328 (Electronic) IS - 2214-031X (Linking) VI - 32 DP - 2022 Jan TI - Kindlin-2 deletion in osteoprogenitors causes severe chondrodysplasia and low-turnover osteopenia in mice. PG - 41-48 LID - 10.1016/j.jot.2021.08.005 [doi] AB - BACKGROUND: Our recent studies demonstrate that the focal adhesion protein Kindlin-2 exerts crucial functions in the mesenchymal stem cells, mature osteoblasts and osteocytes in control of early skeletal development and bone homeostasis in mice. However, whether Kindlin-2 plays a role in osteoprogenitors remains unclear. MATERIALS AND METHODS: Mice lacking Kindlin-2 expression in osterix (Osx)-expressing cells (i.e., osteoprogenitors) were generated. Micro-computerized tomography (muCT) analyses, histology, bone histomorphometry and immunohistochemistry were performed to determine the effects of Kindlin-2 deletion on skeletal development and bone mass accrual and homeostasis. Bone marrow stromal cells (BMSCs) from mutant mice (Kindlin-2 (fl/fl) ; Osx (Cre) ) and control littermates were isolated and determined for their osteoblastic differentiation capacity. RESULTS: Kindlin-2 was highly expressed in osteoprogenitors during endochondral ossification. Deleting Kindlin-2 expression in osteoprogenitors impaired both intramembranous and endochondral ossifications. Mutant mice displayed multiple severe skeletal abnormalities, including unmineralized fontanel, limb shortening and growth retardation. Deletion of Kindlin-2 in osteoprogenitors impaired the growth plate development and largely delayed formation of the secondary ossification center in the long bones. Furthermore, adult mutant mice displayed a severe low-turnover osteopenia with a dramatic decrease in bone formation which exceeded that in bone resorption. Primary BMSCs isolated from mutant mice exhibited decreased osteoblastic differentiation capacity. CONCLUSIONS: Our study demonstrates an essential role of Kinlind-2 expression in osteoprogenitors in regulating skeletogenesis and bone mass accrual and homeostasis in mice. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: This study reveals that Kindlin-2 through its expression in osteoprogenitor cells controls chondrogenesis and bone mass. We may define a novel therapeutic target for treatment of skeletal diseases, such as chondrodysplasia and osteoporosis. CI - (c) 2021 The Authors. FAU - Wu, Xiaohao AU - Wu X AD - Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. FAU - Qu, Minghao AU - Qu M AD - Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. FAU - Gong, Weiyuan AU - Gong W AD - Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. FAU - Zhou, Chunlei AU - Zhou C AD - Department of Medical Laboratory, Tianjin First Center Hospital, Tianjin Medical, 17 University, Tianjin, 300192, China. FAU - Lai, Yumei AU - Lai Y AD - Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 60612, USA. FAU - Xiao, Guozhi AU - Xiao G AD - Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. LA - eng PT - Journal Article DEP - 20210927 PL - Singapore TA - J Orthop Translat JT - Journal of orthopaedic translation JID - 101625127 PMC - PMC8639803 OTO - NOTNLM OT - Chondrodysplasia OT - Kindlin-2 OT - Low-turnover osteopenia OT - Osteoprogenitor OT - Skeletogenesis COIS- The authors declare that they have no competing financial interest. EDAT- 2021/12/23 06:00 MHDA- 2021/12/23 06:01 PMCR- 2021/09/27 CRDT- 2021/12/22 06:50 PHST- 2021/06/28 00:00 [received] PHST- 2021/08/16 00:00 [revised] PHST- 2021/08/18 00:00 [accepted] PHST- 2021/12/22 06:50 [entrez] PHST- 2021/12/23 06:00 [pubmed] PHST- 2021/12/23 06:01 [medline] PHST- 2021/09/27 00:00 [pmc-release] AID - S2214-031X(21)00067-X [pii] AID - 10.1016/j.jot.2021.08.005 [doi] PST - epublish SO - J Orthop Translat. 2021 Sep 27;32:41-48. doi: 10.1016/j.jot.2021.08.005. eCollection 2022 Jan.